Aline Frey

4.3k total citations · 3 hit papers
50 papers, 3.1k citations indexed

About

Aline Frey is a scholar working on Cognitive Neuroscience, Cardiology and Cardiovascular Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Aline Frey has authored 50 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Cognitive Neuroscience, 12 papers in Cardiology and Cardiovascular Medicine and 12 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Aline Frey's work include Heart Failure Treatment and Management (11 papers), Pulmonary Hypertension Research and Treatments (11 papers) and Neuroscience and Music Perception (10 papers). Aline Frey is often cited by papers focused on Heart Failure Treatment and Management (11 papers), Pulmonary Hypertension Research and Treatments (11 papers) and Neuroscience and Music Perception (10 papers). Aline Frey collaborates with scholars based in France, United States and Switzerland. Aline Frey's co-authors include Stephan A. Mayer, Neal F. Kassell, Sébastiên Roux, Isaac Kobrin, Isabel Wanke, Andy Molyneux, Andreas Raabe, E. Keller, Peter Vajkoczy and R. Loch Macdonald and has published in prestigious journals such as New England Journal of Medicine, JAMA and Journal of the American College of Cardiology.

In The Last Decade

Aline Frey

49 papers receiving 3.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Selexipag for the Treatment of Pulmonary Arterial Hypertension

2015 706 citations Olivier Sitbon, Richard N. Channick et al. New England Journal of Medicine profile →
Clazosentan to Overcome Neurological Ischemia and Infarction Occurring After Subarachnoid Hemorrhage (CONSCIOUS-1)

2008 474 citations R. Loch Macdonald, Neal F. Kassell et al. Stroke profile →
Clazosentan, an endothelin receptor antagonist, in patients with aneurysmal subarachnoid haemorrhage undergoing surgical clipping: a randomised, double-blind, placebo-controlled phase 3 trial (CONSCIOUS-2)

2011 453 citations R. Loch Macdonald, Randall T. Higashida et al. The Lancet Neurology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Aline Frey France	21	1.3k	1.2k	1.2k	278	226	50	3.1k
Kiyofumi Yamada Japan	25	679 0.5×	1.1k 0.9×	442 0.4×	180 0.6×	276 1.2×	108	2.0k
Woo‐Keun Seo South Korea	29	525 0.4×	657 0.6×	751 0.6×	95 0.3×	178 0.8×	139	2.4k
Joan Martí‐Fàbregas Spain	33	557 0.4×	859 0.7×	1.2k 1.0×	167 0.6×	557 2.5×	183	3.6k
Nobuo Handa Japan	22	661 0.5×	881 0.8×	458 0.4×	320 1.2×	552 2.4×	45	2.7k
Carmen Ginghină Romania	30	1.5k 1.1×	628 0.5×	1.4k 1.2×	933 3.4×	836 3.7×	143	4.3k
Peter Kapeller Austria	33	387 0.3×	566 0.5×	1.6k 1.4×	433 1.6×	294 1.3×	55	4.0k
Seizo Sadoshima Japan	31	490 0.4×	683 0.6×	905 0.8×	396 1.4×	332 1.5×	142	2.8k
Aleksandra Pavlović Serbia	23	462 0.4×	275 0.2×	272 0.2×	167 0.6×	146 0.6×	130	1.8k
Silvia Morbelli Italy	38	256 0.2×	715 0.6×	1.7k 1.5×	931 3.3×	496 2.2×	257	5.0k
Mi Ji Lee South Korea	30	379 0.3×	712 0.6×	631 0.5×	500 1.8×	239 1.1×	169	3.4k

Countries citing papers authored by Aline Frey

Since Specialization

Citations

This map shows the geographic impact of Aline Frey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aline Frey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aline Frey more than expected).

Fields of papers citing papers by Aline Frey

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aline Frey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aline Frey. The network helps show where Aline Frey may publish in the future.

Co-authorship network of co-authors of Aline Frey

This figure shows the co-authorship network connecting the top 25 collaborators of Aline Frey. A scholar is included among the top collaborators of Aline Frey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aline Frey. Aline Frey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Frey, Aline, et al.. (2023). Impact of Daily Choral Singing and Creative Writing Activities on the Cognitive Development of Second-, Third-, and Fourth-Grade French Children from Low Socioeconomic Backgrounds. Children. 10(9). 1515–1515.

Wanner, Christoph, Virginia Kimonis, Juan Politei, et al.. (2022). Understanding and modifying Fabry disease: Rationale and design of a pivotal Phase 3 study and results from a patient-reported outcome validation study. Molecular Genetics and Metabolism Reports. 31. 100862–100862. 15 indexed citations

Frey, Aline & Marie‐Line Bosse. (2018). Perceptual span, visual span, and visual attention span: Three potential ways to quantify limits on visual processing during reading. Visual Cognition. 26(6). 412–429. 28 indexed citations

Frey, Aline, Benoı̂t Lemaire, Laurent Vercueil, & Anne Guérin-Dugué. (2018). An Eye Fixation-Related Potential Study in Two Reading Tasks: Reading to Memorize and Reading to Make a Decision. Brain Topography. 31(4). 640–660. 12 indexed citations

Sitbon, Olivier, Richard N. Channick, Kelly Chin, et al.. (2015). Selexipag for the Treatment of Pulmonary Arterial Hypertension. New England Journal of Medicine. 373(26). 2522–2533. 706 indexed citations breakdown →

Frey, Aline, Mitsuko Aramaki, & Mireille Besson. (2014). Conceptual priming for realistic auditory scenes and for auditory words. Brain and Cognition. 84(1). 141–152. 10 indexed citations

Macdonald, R. Loch, Randall T. Higashida, E. Keller, et al.. (2012). Randomized Trial of Clazosentan in Patients With Aneurysmal Subarachnoid Hemorrhage Undergoing Endovascular Coiling. Stroke. 43(6). 1463–1469. 228 indexed citations

Macdonald, R. Loch, Randall T. Higashida, E. Keller, et al.. (2012). Randomised Trial of Clazosentan, an Endothelin Receptor Antagonist, in Patients with Aneurysmal Subarachnoid Hemorrhage Undergoing Surgical Clipping (CONSCIOUS-2). Acta neurochirurgica. Supplementum. 115. 27–31. 56 indexed citations

Besson, Mireille, Aline Frey, & Mitsuko Aramaki. (2011). Is the distinction between intra- and extra-musical meaning implemented in the brain?. Physics of Life Reviews. 8(2). 112–3; discussion 125. 3 indexed citations

10.

Milo‐Cotter, Olga, Beth A. Davison, Carlo Lombardi, et al.. (2011). Neurohormonal Activation in Acute Heart Failure: Results from VERITAS. Cardiology. 119(2). 96–105. 53 indexed citations

11.

Macdonald, R. Loch, Randall T. Higashida, E. Keller, et al.. (2011). Clazosentan for patients with subarachnoid haemorrhage: lessons learned – Authors' reply. The Lancet Neurology. 10(10). 871–872. 1 indexed citations

12.

Macdonald, R. Loch, Randall T. Higashida, E. Keller, et al.. (2010). Preventing Vasospasm Improves Outcome After Aneurysmal Subarachnoid Hemorrhage: Rationale and Design of CONSCIOUS-2 and CONSCIOUS-3 Trials. Neurocritical Care. 13(3). 416–424. 48 indexed citations

13.

Macdonald, R. Loch, Neal F. Kassell, Stephan A. Mayer, et al.. (2008). Clazosentan to Overcome Neurological Ischemia and Infarction Occurring After Subarachnoid Hemorrhage (CONSCIOUS-1). Stroke. 39(11). 3015–3021. 474 indexed citations breakdown →

14.

Stevens, David A., et al.. (2008). A Direct Comparison of the Taste of Electrical and Chemical Stimuli. Chemical Senses. 33(5). 405–413. 19 indexed citations

15.

McMurray, John J.V., John R. Teerlink, Gad Cotter, et al.. (2007). Effects of Tezosentan on Symptoms and Clinical Outcomes in Patients With Acute Heart Failure. JAMA. 298(17). 2009–2009. 275 indexed citations

16.

Uriel, Nir, Guillermo Torre‐Amione, Olga Milo, et al.. (2005). Echocardiographic Ejection Fraction in Patients with Acute Heart Failure: Correlations with Hemodynamic, Clinical, and Neurohormonal Measures and Short-Term Outcome. European Journal of Heart Failure. 7(5). 815–819. 22 indexed citations

17.

Cotter, Gad, Edo Kaluski, Karl Stangl, et al.. (2004). The Hemodynamic and Neurohormonal Effects of Low Doses of Tezosentan (An Endothelin A/B Receptor Antagonist) in Patients with Acute Heart Failure. European Journal of Heart Failure. 6(5). 601–609. 51 indexed citations

18.

Kaluski, Edo, Isaac Kobrin, Reuven Zimlichman, et al.. (2003). RITZ-5: randomized intravenousTeZosentan (an endothelin-A/B antagonist)for the treatment of pulmonary edema. Journal of the American College of Cardiology. 41(2). 204–210. 98 indexed citations

19.

O’Connor, Christopher M., Wendy A. Gattis, Kirkwood F. Adams, et al.. (2003). Tezosentan in patients with acuteheart failure and acute coronary syndromes. Journal of the American College of Cardiology. 41(9). 1452–1457. 118 indexed citations

20.

O’Connor, Christopher M., Wendy A. Gattis, Kirkwood F. Adams, et al.. (2003). Tezosentan in patients with acute heart failure and acute coronary syndromes: Design of the fourth Randomized Intravenous Tezosentan Study (RITZ-4). American Heart Journal. 145(2). S58–S59. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact